Should Bevacizumab Be Continued After Progression on Bevacizumab in Recurrent Ovarian Cancer?
Floor J. Backes, Debra L. Richardson, Georgia A. McCann, Blair Smith, Ritu Salani, Eric L. Eisenhauer, Jeffrey M. Fowler, Larry J. Copeland, David E. Cohn, David M. O’Malley
International Journal of Gynecologic Cancer Jun 2013, 23 (5) 833-838; DOI: 10.1097/IGC.0b013e318290ea69